Adenovirus-mediated HSV-TK Gene Therapy Using hTERT Promoter in CNE Cells in vitro

被引:0
|
作者
Zhang Yu [1 ,3 ]
Yu Xiang-hui [3 ]
Zha Xiao [1 ,2 ]
Kong Wei [3 ]
机构
[1] Sichuan Tumor Hosp, Dept Radiotherapy, Chengdu 610041, Peoples R China
[2] Sichuan Tumor Hosp, Dept Mol Pharmacol, Chengdu 610041, Peoples R China
[3] Jilin Univ, Coll Life Sci, Vaccine Res Ctr, Changchun 130012, Peoples R China
基金
中国国家自然科学基金;
关键词
hTERT; HSV-TK; Adenovirus; Nasopharyngeal carcinoma; NASOPHARYNGEAL CARCINOMA;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Human telomerase reverse transcriptase(hTERT) activity was detected in human nasopharyngeal carcinoma cell(CNE) but not in human normal lung fibroblast(CCD-11Lu). Recombinant adenoviruses Ad-CMV-TK-enh and Ad-hTERT-TK-enh were constructed and infected into normal fibroblasts and nasopharyngeal carcinoma cells. Ad-CMv-TK-enh with 100 [mu mol/L of ganciclovir(GCV) caused 87% of CCD-11Lu cells death and 91% of CNE cells death, Ad-hTERT-TK-enh with 100 mu mol/L of GCV caused 24% of CCD-11Lu cells death and 79% of CNE cells death. These results indicate that the Ad-hTERT-TK-enh with GCV may be a useful method in suppressing tumor growth in targeted nasopharyngeal carcinoma gene therapy.
引用
收藏
页码:60 / 63
页数:4
相关论文
共 50 条
  • [41] Adenovirus-mediated gene therapy for bladder cancer: efficient gene delivery to normal and malignant human urothelial cells in vitro and ex vivo
    Chester, JD
    Kennedy, W
    Hall, GD
    Selby, PJ
    Knowles, MA
    GENE THERAPY, 2003, 10 (02) : 172 - 179
  • [42] Gene therapy for ovarian cancer using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene directed by MDR1 promoter
    Lu, Shi
    Wang, Xiaoyi
    Xiao, Lan
    Cai, Liqiong
    Zhang, Yuan
    Wang, Hongbo
    Wang, Zehua
    CANCER BIOLOGY & THERAPY, 2007, 6 (03) : 397 - 404
  • [43] Characterization of HIV-1 TAT peptide as an enhancer of HSV-TK/GCV cancer gene therapy
    O Rautsi
    S Lehmusvaara
    A Ketola
    A-M Määttä
    J Wahlfors
    R Pellinen
    Cancer Gene Therapy, 2008, 15 : 303 - 314
  • [44] GENE-THERAPY FOR HEPATOCELLULAR-CARCINOMA - CHEMOSENSITIVITY CONFERRED BY ADENOVIRUS-MEDIATED TRANSFER OF THE HSV-1 THYMIDINE KINASE GENE
    WILLS, KN
    HUANG, WM
    HARRIS, MP
    MACHEMER, T
    MANEVAL, DC
    GREGORY, RJ
    CANCER GENE THERAPY, 1995, 2 (03) : 191 - 197
  • [45] Lentiviral HSV-Tk.007-mediated suicide gene therapy is not toxic for normal brain cells
    Hossain, Jubayer A.
    Ystaas, Lars Romo
    Mrdalj, Jelena
    Valk, Kristjan
    Riecken, Kristoffer
    Fehse, Boris
    Bjerkvig, Rolf
    Gronli, Janne
    Miletic, Hrvoje
    JOURNAL OF GENE MEDICINE, 2016, 18 (09) : 234 - 243
  • [46] Fiber-modified adenovirus-mediated suicide gene therapy can efficiently eliminate bladder cancer cells in vitro and in vivo
    Wang, De-Gui
    Zhao, Mei-Jun
    Liu, Yong-Qiang
    Liu, Xiang-Wen
    Niu, Hai-Tao
    Song, Yan-Feng
    Tian, Ying-Xia
    ONCOTARGET, 2016, 7 (44) : 71710 - 71717
  • [47] Local inflammation and devascularization -: in vivo mechanisms of the "bystander effect" in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma
    Floeth, FW
    Shand, N
    Bojar, H
    Prisack, HB
    Felsberg, J
    Neuen-Jacob, E
    Aulich, A
    Burger, KJ
    Bock, WJ
    Weber, F
    CANCER GENE THERAPY, 2001, 8 (11) : 843 - 851
  • [48] Advances in adenovirus-mediated p53 cancer gene therapy
    Tazawa, Hiroshi
    Kagawa, Shunsuke
    Fujiwara, Toshiyoshi
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (11) : 1569 - 1583
  • [49] Local inflammation and devascularization — in vivo mechanisms of the “bystander effect” in VPC-mediated HSV-Tk/GCV gene therapy for human malignant glioma
    Frank W Floeth
    Nick Shand
    Hans Bojar
    Hans B Prisack
    Jörg Felsberg
    Eva Neuen-Jacob
    Albrecht Aulich
    Klaus J Burger
    Wolfgang J Bock
    Friedrich Weber
    Cancer Gene Therapy, 2001, 8 : 843 - 851
  • [50] The combination of HSV-tk and endostatin gene therapy eradicates orthotopic human renal cell carcinomas in nude mice
    Kalevi Juhani Pulkkanen
    Johanna M Laukkanen
    Jonas Fuxe
    Mikko I Kettunen
    Marko Rehn
    Jani M Kannasto
    Jyrki J Parkkinen
    Risto A Kauppinen
    Ralf F Pettersson
    Seppo Yla-Herttuala
    Cancer Gene Therapy, 2002, 9 : 908 - 916